gut.bmj15d
Gene score to quantify systemic inflammation in patients with acutely decompensated cirrhosis
Background and aims Quantifying systemic inflammation (SI) in acutely decompensated cirrhosis (ADC) is of major importance because SI is a driver of the most severe forms of ADC, including ...
gut.bmj24d
Reparative immunological consequences of stem cell transplantation as a cellular therapy for refractory Crohn’s disease
Background Treatment strategies for Crohn’s disease (CD) suppress diverse inflammatory pathways but many patients remain refractory to treatment. Autologous haematopoietic stem cell transplantation ...
gut.bmj18h
Cautious view on the link between yoghurt consumption and risk of colorectal cancer
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...
gut.bmj13d
Diagnosis of nasopharyngeal disease during upper GI endoscopy
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...
gut.bmj3d
PMO-076 Assessment of the probiotic symprove in patients with IBS: a randomised double blind placebo controlled trial
2 Department of Primary Care and Public Health Sciences, King's College London, London, UK Methods Material and Methods: This was a single centre, double blind, randomised, placebo controlled trial ...
gut.bmj1d
Acute toxic gastric mucosal damage induced by Lugol’s iodine spray during chromoendoscopy
1 Department of Gastroenterology, The General Infirmary at Leeds, Leeds, UK 2 Department of Histopathology, The General Infirmary at Leeds, Leeds, UK 3 Department of Gastroenterology, The General ...
gut.bmj6d
Tight junction proteins in gastrointestinal and liver disease
Over the past two decades a growing body of evidence has demonstrated an important role of tight junction (TJ) proteins in the physiology and disease biology of GI and liver disease. On one side, TJ ...
gut.bmj5d
PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis
1 Division of Gastroenterology and Hepatology, Mayo Clinic and Foundation, Rochester, MN, USA 2 Division of Biostatistics, Mayo Clinic and Foundation, Rochester, MN, USA Correspondence to: Dr E V ...
gut.bmj4d
Apoptosis, necrosis and necroptosis: cell death regulation in the intestinal epithelium
Department of Medicine 1, University of Erlangen-Nuremberg, Erlangen, Germany Correspondence to Dr Christoph Becker, 1. Department of Medicine, University of Erlangen-Nuremberg, Hartmannstrasse 14, 91 ...
gut.bmj4d
Butyrate inhibits inflammatory responses through NFκB inhibition: implications for Crohn's disease
Professor J P Galmiche, Centre de Recherche en Nutrition Humaine, CRI INSERM 95-08, CHU, Hôtel Dieu, Place A Ricordeau, 44035 Nantes cedex 01, France. Email:galmiche{at}easynet.fr BACKGROUND/AIM ...
gut.bmj2d
PMO-5 Steroids and tapering regimes in Inflammatory Bowel Disease – What do we prescribe?
Introduction Steroids have been an established treatment in flares of inflammatory bowel disease (IBD) for the past 50 years. Whilst evidence exists to guide the initial dose of these drugs, data ...
gut.bmj19d
RNA-based therapies in liver metabolic diseases
RNA-based therapeutics have rapidly emerged over the past decade, offering a new class of medicines that differ significantly from conventional drugs. These therapies can be programmed to target or ...